|
Performance Summary
The financial year 2025-26 reflects Prevest DenPro Limited's continued
commitment to innovation, excellence, and sustainable growth. Guided by our vision of
advancing dental healthcare, we have remained focused on delivering high-quality,
science-driven solutions while strengthening our global presence. Our unwavering
dedication to customer satisfaction and operational excellence continues to create lasting
value for all our stakeholders.
Throughout the year, the Company reinforced its strategic priorities
through continuous investments in research and development, technological advancement, and
manufacturing capabilities. Supported by strong corporate governance and responsible
leadership, we have fostered a culture of integrity, resilience, and continuous
improvement ^ that enables us to respond effectively to evolving industry needs and
emerging opportunities across international markets.
As we look to the future, Prevest DenPro Limited remains committed to
building a resilient and purpose-driven enterprise. With the trust of our shareholders,
customers, employees, and business partners, we are well-positioned to accelerate our
growth journey and shape the future of dental healthcare through innovation,
collaboration, and sustainable value creation for generations to come.
To,
The Members,
Prevest Denpro Limited
Your Directors are pleased to present their 27th Annual Report on the
business and operations of the Company together with the Audited Financial Statements for
the Financial Year ended March 31,2026.
FINANCIAL AND OPERATIONAL PERFORMANCE
(Amount in Rs. Lakh)
| Particulars |
Standalone |
Consolidated |
|
Year ended March 31,2026 |
Year ended March 31, 2025 |
Year ended March 31, 2026 |
Year ended March 31, 2025 |
Total Income (Revenue) |
7,666.12 |
6717.76 |
7,672.36 |
6,709.42 |
Less: Expenses |
4,812.08 |
4,290.49 |
4,911.12 |
4,284.44 |
Profit/(Loss) before taxation |
2,854.04 |
2,427.27 |
2,761.23 |
2,424.97 |
Less: Tax Expense |
712.22 |
607.14 |
712.19 |
609.46 |
Profit/(Loss) after tax |
2,141.82 |
1,820.13 |
2,049.05 |
1,815.52 |
Results Of Operations & State Of Company's
Affairs
During FY 2025-26, the Company has earned a profit before tax of Rs.
2,854.04 Lakh and an after-tax profit of Rs. 2,141.82 Lakh, as against a profit before tax
of Rs. 2,427.27 Lakh and an after-tax profit of Rs. 1,820.13 Lakh during FY 2024-25.
During FY 2025-26, the Company has earned a consolidated profit before
tax of Rs. 2,761.23 Lakh and an after-tax profit of Rs. 2,049.05 Lakh, as against a profit
before tax of Rs. 2,424.97 Lakh and an after-tax profit of Rs. 1,815.52 Lakh during FY
2024-25.
The Company continues to focus on strengthening its operational
framework and establishing a solid foundation for future growth. Your directors remain
confident in the Company's long-term prospects and are optimistic about continued
improvement in performance in the years ahead.
Change In Nature Of Business:
There is no change in the nature of business of the company during the
financial year 2025-2026.
Dividend
The Board of Directors, after reviewing the Company's performance for
the financial year 2025-26, has recommended a dividend of Rs. 1 (Rupees One) per equity
share. This reflects the Company's ongoing efforts to enhance shareholder value and share
the benefits of its performance with all stakeholders.
The proposed dividend is subject to approval of the shareholders at the
ensuing Annual General Meeting. In accordance with applicable provisions of the Income-tax
Act, 1961, tax will be deducted at source from the dividend amount payable to the Members.
Transfer To Reserves
During the year under review, no amount is proposed to be transferred
to the General Reserve of the Company.
Share Capital
The paid-up share capital of the Company as on March 31,2026, was Rs.
12,00,30,000, comprising 1,20,03,000 equity shares of Rs. 10 each, fully paid-up. During
the year under review, the Company has not issued any additional shares.
The Company has also not issued any shares with differential voting
rights or sweat equity shares during the year, and accordingly, no disclosures are
required under Rule 8(13) of the Companies (Share Capital and Debentures) Rules, 2014.
Further, there are no shares held by trustees for the benefit of
employees; hence, the provisions of Rule 16(4) of the said Rules are not applicable.
Public Deposits
During the year under review, the Company has not accepted any deposits
within the meaning of Chapter V of the Companies Act, 2013. Accordingly, the provisions
relating to acceptance of deposits are not applicable.
Subsidairy And Associates Companies
As on March 31,2026, the Company has three wholly owned subsidiaries:
Denvisio Biomed Limited
Axiodent Inc.
Prevest Denpro Gulf General Trading L.L.C
Pursuant to Section 129(3) of the Act, a statement containing the
salient features of the financial statements of the Company's subsidiaries, associates,
and joint ventures, in the prescribed format Form AOC-1, is annexed to this Report as Annexure
A.
Consolidated Financial Statements
In accordance with the provisions of the Companies Act, 2013 (the
Act) and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, the
Audited Consolidated Financial Statements of the Company form part of this Annual Report
for the financial year 2025-26.
In accordance with Section 136 of the Act, the financial statements of
the subsidiaries are also made available on the Company's website at www.prevestdenpro.com.
under the Investors section.
MATERIAL CHANGES AND COMMITMENTS, IF ANY, AFFECTING THE FINANCIAL
POSITION OF THE COMPANY WHICH HAVE OCCURRED BETWEEN THE END OF THE FINANCIAL YEAR OF THE
COMPANY TO WHICH THE FINANCIAL STATEMENTS RELATE AND THE DATE OF THE REPORT;
There are no material changes and commitments affecting the financial
position of the Company between the end of the financial year and the date of this report.
Statutory Auditors And Statutory Audit Report
The members at the 22nd Annual General Meeting had appointed M/s.
Mittal & Associates, Chartered Accountant, (Firm Registration No. 106456W) as a
Statutory Auditors of the Company for a period of five years, from the conclusion of the
22nd Annual General Meeting until the conclusion of the 27th Annual General Meeting of the
Company.
The Auditor's Report on the financial statements for the year ended
March 31,2026, does not contain any qualification, reservation, or adverse remark.
The Notes regarding the financial statements, as referred to in the
Auditors' Report, are selfexplanatory and do not require any further explanation from the
Board.
Moreover, The Board of Directors at its Meeting held on May 27,2026
proposed the appointment of M/s. A D V & Associates, Chartered Accountant, (Firm
Registration No. 128045W) as the Statutory Auditors of the Company for a period of five
years, from the conclusion of the 27th Annual General Meeting until the conclusion of the
32nd Annual General Meeting of the Company.
The Statutory Auditors have confirmed that they satisfy the
Independence criteria required under the Companies Act, 2013 and Code of Ethics issued by
the Institute of Chartered Accountants of India and also confirm that they are eligible to
continue with their appointment and that they have not been disqualified in any manner
from continuing as Statutory Auditor.
Secretarial Auditors And Secretarial Audit Report
Pursuant to the provisions of Section 204 of the Companies Act, 2013,
read with the Companies (Appointment and Remuneration of Managerial Personnel) Rules,
2014, the Company has appointed NKM & Associates, a firm of Company Secretaries in
Practice, to carry out the Secretarial Audit for the financial year ended March 31,2026.
The Secretarial Audit Report issued by the Secretarial Auditor is
annexed to the Report as Annexure B. The Report does not contain any
qualifications, reservations, or adverse remarks.
Internal Auditors
In accordance with the provisions of Section 138 of the Companies Act,
2013, read with Rule 13 of the Companies (Accounts) Rules, 2014, and other applicable
provisions, if any, the Company has appointed M/s VNB and Company, Chartered Accountants,
as the Internal Auditors of the Company. The Internal Auditors periodically review the
adequacy of internal control systems and the efficiency of business processes, and their
findings and recommendations are reviewed by the Audit Committee from time to time for
implementation and continuous improvement.
Cost Audit
Pursuant to the provisions of Section 148 of the Companies Act, 2013,
read with the Companies (Cost Records and Audit) Rules, 2014, the Company has appointed
PAN & Associates, Cost Accountants, as the Cost Auditors of the Company for the
financial year 2025-26 to carry out the audit of the cost records maintained by the
Company.
The Company continues to comply with the requirement of maintaining
cost records as prescribed under the Act.
The particulars of loans, guarantees, and investments made by the
Company during the financial year, as required under the provisions of Section 186 of the
Companies Act, 2013, are disclosed in the notes to the financial statements, which form an
integral part of this Annual Report.
Further, pursuant to Paragraph A(2) of Schedule V of the SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015, the details of loans and
advances given to subsidiaries have also been provided in the notes to the financial
statements forming part of the Annual Report.
Particulars Of Remuneration Of Directors And
Certain Specified Employees:
Disclosures pertaining to remuneration and other details as required
under Section 197(12) of the Companies Act, 2013, read with Rule 5(1) of the Companies
(Appointment and Remuneration of Managerial Personnel) Rules, 2014, and the Companies
(Particulars of Employees) Rules, 1975, are annexed to this Report as Annexure
C.
Further, pursuant to Rule 5(2) and Rule 5(3) of the Companies
(Appointment and Remuneration of Managerial Personnel) Rules, 2014, the particulars of
employees, as prescribed under the said Rules, are provided below.
The Company confirms that the employment of the employees mentioned
herein is permanent in nature and not contractual.
| Name |
Designation |
Remuneration |
Experience in Company |
Q ualification |
Date of joining |
Age |
Name of the Previous Employer |
| Mr. Atul Modi |
Managing Director |
Rs.1.425 Cr |
27 years |
BE(Mechanical) |
05/05/1999 |
72 |
- |
| Mrs. Namrata Modi |
Whole-Time Director and CFO |
Rs.1.425 Cr |
27 years |
MBA |
05/05/1999 |
68 |
|
| Mr. Vaibhav Munjal |
Director and Chief Marketing Director |
Rs.1.36 Cr |
3 year |
BE(Mechanical) and MBA |
27/04/2023 |
42 |
Samsung India |
Disclosure About The Receipt Of Commission
In terms of Section 197(14) of the Act and rules made there under,
during the year under review, Mr. Vaibhav Munjal, Director of the Company, has received
commission from the Company, pursuant to special resolution passed on AGM dated 30th
August, 2023.
Risk Management Policy:
The Board of Directors of your Company have identified industry
specific risk and other external, internal, political and technological risk which in
opinion of the board are threat to the Company and Board has taken adequate measures and
actions which are required to take for diminishing the adverse effect of the risk.
The Risk Management Policy of the Company is available on the website
and can be accessed at: www.prevestdenpro.com.
Details In Respect Of Fraud Reported By Auditors:
Pursuant to Section 143(12) of the Act, during the year under review
there were no frauds reported by the Statutory Auditors, Internal Auditors, Cost Auditors
and Secretarial Auditors of the Company to the Audit Committee or the Board of Directors.
Hence, there is nothing to report under Section 134(3)(ca) of the Act.
Conservation Of Energy, Technology, Absorption And
Foreign Exchange Earnings And Outgo
Details required to be furnished pursuant to Section 134(3)(m) of the
Companies Act, 2013 are as under: Conservation of Energy:
As a manufacturer of dental materials and oral care products, our
operations are not energy-intensive by nature. However, the Company continues to focus on
responsible energy use. Efforts are made to ensure electricity is used efficiently by
installing energy-saving devices and maintaining equipment regularly to avoid unnecessary
consumption.
We have also adopted LED lighting, power-efficient systems, and
automated machinery that consume less power while delivering consistent performance. While
these measures don't have a major financial impact due to our industry profile, they
reflect our ongoing commitment to energy-conscious practice. Technology Absorption: We
believe that technology and quality go hand in hand, especially in the dental care
industry where precision and safety are paramount. Over the past year, we have continued
to invest in improving our production capabilities by using modern machinery and precision
tools.
Our production floors are equipped with advanced quality control
equipment, and we have a dedicated team that oversees strict compliance with manufacturing
standards. The focus remains on delivering products that meet both domestic and
international expectations.
We also keep an eye on global advancements and are prepared to upgrade
our infrastructure as and when needed. This readiness to adopt new technologies helps us
stay competitive and ensures we continue offering reliable, high-quality dental solutions
to our customer.
Foreign Exchange Earnings and Outgo:
(Amount in Rs. Crore)
| Sl. No Particulars |
As at March 31,2026 |
As at March31,2025 |
| 01 Foreign Exchange Earnings |
39.05 |
35.87 |
| 02 Foreign Exchange Outgo |
14.98 |
13.02 |
Research And Development:
The Company has a fully functional Research and Development Centre at
its manufacturing unit, which continues to play an important role in supporting our
efforts to develop and improve dental materials and oral care products.
During the year, the R&D team focused on improving product
stability, exploring new formulations, and aligning our products with changing industry
requirements, especially in terms of safety, performance, and regulatory standards.
The Centre is equipped with the necessary tools and facilities required
for lab-scale development, testing, and product evaluation.
Human Resources:
Your Company treats its "Human Resources" as one of its most
important assets. Your Company continuously invests in attraction, retention and
development of talent on an ongoing basis, You Company thrust is on the promotion of
talent internally through job rotation and job enlargement. The Company maintains healthy,
cordial and harmonious industrial relation at all levels. The enthusiasm amongst employees
has enabled the Company to remain at a leadership position in the industry.
Corporate Governance:
As a Small and Medium-sized Enterprise (SME) listed on the SME exchange
of BSE Limited, the company is exempt from complying with certain corporate governance
provisions. Specifically, pursuant to Regulation 15(2) of SEBI (Listing Obligations and
Disclosure Requirements) Regulation, 2015, compliance with corporate governance
requirements specified in Regulations 17, 17A, 18, 19, 20, 21, 22, 24, 24A, 25, 26, 26A,
27 and clauses (b) to (i) of sub-regulation (2) of regulation 46 and para C, D, and E of
Schedule V is not mandatory.
Further, please note that your Company has a paid-up equity share
capital exceeding Rupees ten crore and a
net worth exceeding Rupees twenty-five crore, as on the last day of the
previous financial year. Accordingly, the provisions of Regulation 23 are applicable.
Corporate governance does not form part of this Board's Report.
However, please be assured that the company is committed to adhering to
good corporate governance practices. We are working diligently to ensure that our
governance practices align with the highest standards and contribute to the overall
integrity and transparency of the organization.
Management Discussion And Analysis
The Management Discussion and Analysis Report for the year under
review, as required under Regulation 34(2)(e) of the SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015, is provided in a separate section and forms an
integral part of this Annual Report for the financial year ended March 31, 2026.
Board Of Directors And Key Managerial Personnel
As on March 31, 2026 the company's Board has a strength of Six (06)
Directors including Two (2) women Director. The Composition of the board is as below:
| Sl. No. Name of the
Director |
Category |
Number of other Directorshi ps held in
other public/List ed companies |
Number of Committee
membership held in other public companies (limited to only Audit and Stakeholders?
Relationship Committees) |
% of Equity Shares held in the Company
(%) |
|
|
|
As Chairperson |
As Member |
|
| 1 Mr. Atul Modi |
Chairman, Managing Director |
1 |
Nil |
Nil |
37.52.% |
| 2 Mrs. Namrata Modi |
Whole Time Director, CFO |
1 |
Nil |
Nil |
36.03% |
| 3 Dr. Sai Kalyan Surapaneni |
Director Research |
1 |
Nil |
Nil |
0.00083% |
| 4 Mr. Vaibhav Munjal |
Director and CMO |
1 |
Nil |
Nil |
Nil |
| 5 Mrs. Niharika Modi |
Non-Executive Director |
Nil |
Nil |
Nil |
0.03% |
| 6 CA Pardeep Gandotra |
Non-Executive Independent Director |
Nil |
Nil |
Nil |
Nil |
During the year under review, the following changes took place in the
Key Managerial Personnel of the Company:
Mrs. Namrata Modi was re-appointed as the Whole-time Director of the
Company with effect from December 21, 2025, pursuant to the resolution passed by the Board
of Directors on December 20, 2025, for a term of three (3) years, subject to the approval
of the Members.
Mr. Sai Kalyan Surapaneni was re-appointed as the Executive Director of
the Company with effect from December 21, 2025, pursuant to the resolution passed by the
Board of Directors on December 20, 2025, for a term of three (3) years, subject to the
approval of the Members.
( Mr. Nikhil Shrikant Bobade and Mr. Sudeep Murthy ceased to hold
office as Independent Directors of the Company upon completion of their respective terms
of office, with effect from the close of business hours on March 16, 2026.
After the closure of financial year, the following changes took place
in the Key Managerial Personnel of the Company:
Mr. Pardeep Gandotra ceased to hold office as an Independent Director
of the Company upon completion of his term of office, with effect from the close of
business hours on April 26, 2026.
Mr. Piyush Kiranprakash Gupta was appointed as Additional Directors in
the capacity of Non-Executive Independent Directors of the Company for a term of five(5)
consecutive years with effect from April 22, 2026, subject to the approval of the Members.
Mr. Abhijeet Sadashiv Haridas Gupta was appointed as Additional
Directors in the capacity of Non Executive Independent Directors of the Company for a term
of five(5) consecutive years with effect from April 22, 2026, subject to the approval of
the Members.
Mr. Sukhen Pal Babuta was appointed as an Additional Director in the
capacity of Non-Executive Independent Director of the Company for a term of five (5)
consecutive years with effect from May 27, 2026, subject to the approval of the Members.
Mr. Aman Sadhotra resigned from the office of Company Secretary and
Compliance Officer of the Company with effect from April 6, 2026.
Mr. Pratul Gupta was appointed as the Company Secretary and Compliance
Officer of the Company with effect from May 27, 2026
Retire By Rotation
In accordance with the provisions of Section 152 of the Act read with
rules thereunder and the Articles of Association of the Company, Mrs. Niharika Modi (DIN:
07818057), retires by rotation at the ensuing Annual General Meeting (AGM") and
being eligible, has offered herself for re-appointment. In compliance with Secretarial
Standard-2, the brief resume, expertise and other details of Mrs. Niharika Modi (DIN:
07818057) is given in the notice convening this AGM. Based on the recommendations of the
Nomination and Remuneration (NRC") of the Company, the Board has recommended
her reappointment as Director at the ensuing AGM.
Directors' Responsibility Statement
Pursuant to the provisions of section 134(5) of the Companies Act,
2013, the Directors confirm that.
In the preparation of the annual accounts for the Financial Year ended
March 31,2026, the applicable accounting standards have been followed along with proper
explanation relating to material departures;
They have selected such accounting policies and applied them
consistently and made judgments and estimates that are reasonable and prudent so as to
give a true and fair view of the state of affairs of your Company as at March 31, 2026 and
of the profits of the Company for the period ended on that date;
Q Proper and sufficient care have been taken for the maintenance of
adequate accounting records in accordance with the provisions of Act for safeguarding the
assets of your Company and for preventing and detecting fraud and other irregularities;
? The annual accounts have been prepared on a going concern basis;
? Proper internal financial controls laid down by the Directors were
followed by the Company and that such internal financial controls were adequate and
operating effectively; and
? Proper systems to ensure compliance with the provisions of all
applicable laws were in place and that such systems were adequate and operating
effectively.
Number Of Meetings Board Of Directors
During the Financial Year 2025-26, seven meetings of the Board were
held on the following dates:
May 27, 2025; June 29, 2025; August 13, 2025; October 25, 2025;
November 12, 2025; December 20, 2025 and February 14, 2026.
The gap between any two meetings did not exceed one hundred and twenty
days. The necessary quorum was present for all the meetings.
Attendance of Directors at the Board Meetings held during the financial
year 2025-26:
| Name of the Directors |
Board Meetings entitled to attend |
Board Meetings attended |
| Mr. Atul Modi |
7 |
7 |
| Mrs. Namrata Modi |
7 |
7 |
| Dr. Sai Kalyan Surapaneni |
7 |
7 |
| Mr. Vaibhav Munjal |
7 |
4 |
| Mrs. Niharika Modi |
7 |
N='RIGHT'>4 |
| CA Pardeep Gandotra |
7 |
1 |
| Dr. Nikhil Shrikant Bobade |
7 |
4 |
| Dr. Sudeep Haralakatte Murthy |
7 |
4 |
The Board Meetings are prescheduled, and adequate notice is given to
the Board embers. Board Meetings are generally held at the registered office of the
Company either through video conference or through physical presence.
Independent Directors
Pursuant to the provisions of Section 149 of the Act and SEBI Listing
Regulations, the Independent Directors have submitted declarations stating that each of
them fulfils the criteria of independence as provided in Section 149(6) of the Act along
with rules framed thereunder and Regulation 16(1)(b) of the SEBI Listing Regulations.
There has been no change in the circumstances affecting their status as
Independent Directors of the Company. In the opinion of the Board, the Independent
Directors are competent, experienced, proficient and possess the necessary expertise and
integrity to discharge their duties and functions as Independent Directors. The
Independent Directors of the Company have undertaken requisite steps towards the inclusion
of their names in the data bank of Independent Directors maintained with the Indian
Institute of Corporate Affairs.
The Independent Directors have complied with the Code of Conduct
prescribed under Schedule IV of the Act and the declaration by Independent Directors had
also been submitted by them.
Further, none of the Company's Directors are disqualified from being
appointed as a director as specified in Section 164 of the Act. All Directors have further
confirmed that they are not debarred from holding the office of a director under any order
from SEBI or any other such authority.
During the financial year 2025-26, one (1) meeting of the Independent
Directors was held on February 01, 2026, inter-alia, to review the following:
? Review performance of non-independent directors and the Board of
Directors as a whole.
? Review performance of the Chairperson of the Company.
? Assess the quality, quantity, and timeliness of the flow of
information between the management of the Company and the Board of Directors that is
necessary for the Board to perform their duties effectively and reasonably.
The meeting was attended by all the Independent Directors.
The familiarization program and other disclosures as specified under
SEBI (LODR) Regulations, 2015 is available on the Company's website www.prevestdenpro.com
Annual Evaluation Of Performance By The Board, Its
Committees And Of Individual Directors:
Pursuant to the applicable provisions of the Act and the SEBI Listing
Regulations, the Board of Directors has put in place a process to formally evaluate the
effectiveness of the Board along with performance evaluation of each Director to be
carried out on an annual basis. The performance evaluation was carried out by the NRC in
its meeting. The recommendations of the Committee were subsequently considered by the
Board thereby concluding the performance evaluation process.
The evaluation was conducted via a questionnaire containing qualitative
questions with responses provided on a rating scale. Evaluation was based on criteria such
as the composition of the Board and its Committees, their functioning, communication
between the Board, its Committees and the management of the Company and performance of the
Directors and Chairperson of the Board based on their participation in effective decision
making and their leadership abilities.
The outcome of the performance evaluation as carried out on the basis
of the above mechanism was discussed by the NRC and the Board at their respective meetings
and noted the performance to be satisfactory and it also reflected the commitment of the
Board members and its Committees to the Company
Committees Of The Board
Audit Committee
Composition of the Committee and Meetings held and attended by each
member:
| Name of the Member |
Category |
Designation |
Meetings |
|
|
|
Held |
Attended |
| Dr. Sudeep Haralakatte Murthy |
Independent Director |
Chairperson |
4 |
4 |
| Dr. Nikhil Shrikant Bobade |
Independent Director |
Member |
4 |
4 |
| Mrs. Namrata Modi |
Executive Director |
Member |
4 |
4 |
The Audit Committee is duly constituted in accordance with Section 177
of the Act read with Rule 6 of the Companies (Meetings of Board and its Powers) Rules,
2014. It adheres to the terms of reference, prepared in compliance with Section 177 of the
Act, and the SEBI Listing Regulations to the extent applicable. The Audit Committee of the
Company is entrusted with the responsibility to supervise the Company's internal controls
and financial reporting process. The Committee acts as a link between the Management, the
Statutory Auditors, the Internal Auditors, Secretarial Auditors and the Board of
Directors.
Subsequent to the close of the financial year ended March 31, 2026,
pursuant to the appointments and cessation of Directors on the Board, the Audit Committee
was reconstituted with effect from April 22, 2026 as under:
| Name of the Member |
Category |
Designation |
| Dr. Piyush Kiranprakeash Gupta |
Independent Director |
Chairman |
| Dr. Abhijeet Sadashiv Haridas |
Independent Director |
Member |
| Mrs. Namrata Modi |
Whole Time Director & CFO |
Member |
The reconstituted Audit Committee continues to function in accordance
with the applicable provisions of the Companies Act, 2013, the SEBI (Listing Obligations
and Disclosure Requirements) Regulations, 2015, and its terms of reference.
Nomination And Remuneration Committee
Composition of the Committee and Meetings attended by each member:
| Name of the Member |
Category |
Designation |
Meetings |
|
|
|
Held |
Attended |
| Dr. Nikhil Shrikant Bobade |
Independent Director |
Chairperson |
1 |
1 |
| Mrs. Niharika Modi |
Non-Executive Director |
Member |
1 |
1 |
| Dr. Sudeep Haralakatte Murthy |
Independent Director |
Member |
1 |
1 |
The Nomination and Remuneration Committee has been constituted in order
to bring about objectivity in determining the remuneration package while striking a
balance between the interest of the Company and the shareholders. As per the provisions of
the Act and the SEBI Listing Regulations, the Nomination and Remuneration Committee (the
Committee) has laid down the evaluation criteria for performance evaluation of
Independent Directors and the Board. The manner for performance evaluation of Directors
(including Independent Directors) and Board as whole has been covered in the Board's
Report.
Subsequent to the close of the financial year ended March 31, 2026,
pursuant to the appointments and cessation of Directors on the Board, the Nomination and
Remuneration Committee was reconstituted with effect from April 22, 2026 as under:
| Name of the Member |
Category |
Designation |
| Dr. Abhijeet Sadashiv Haridas |
Independent Director |
Chaiiperson |
| Dr. Piyush Kiranprakeash Gupta |
Independent Director |
Member |
| Mrs. Niharika Modi |
Non-Executive Director |
Member |
The reconstituted Nomination and Remuneration Committee continues to
function in accordance with the applicable provisions of the Companies Act, 2013, the SEBI
(Listing Obligations and Disclosure Requirements) Regulations, 2015, and its terms of
reference.
Stakeholder Relationship Committee
Composition of the Committee and Meetings held and attended by each
member:
| Name of the Category |
Member |
Designation |
Meetings |
|
|
|
Held |
Attended |
| Mr. Atul Modi |
Managing Director |
Chairperson |
1 |
1 |
| Mrs. Namrata Modi |
Executive Director |
Member |
1 |
1 |
| Dr. Nikhil Shrikant Bobade |
Independent Director |
Member |
1 |
1 |
During the financial year 2025-26, the Committee met once to review and
resolve shareholder grievances and queries. All members of the Committee were present
during the meeting.
Subsequent to the close of the financial year ended March 31, 2026,
pursuant to the appointments and cessation of Directors on the Board, the Stakeholder
Relationship Committee was reconstituted with effect from April 22, 2026 as under:
| Name of the Member |
Category |
Designation |
| Dr. Piyush Kiranprakeash Gupta |
Independent Director |
Chairperson |
| Mrs. Atul Modi |
Managing Director |
Member |
| Mrs. Namrata Modi |
Whole Time Director & CFO |
Member |
The reconstituted Nomination and Remuneration Committee continues to
function in accordance with the applicable provisions of the Companies Act, 2013, the SEBI
(Listing Obligations and Disclosure Requirements) Regulations, 2015, and its terms of
reference.
Corporate Social Responsibility (csr) Committee
Your Company believes that Corporate Social Responsibility (CSR) is an
integral part of its business. It seeks to operate its business in a sustainable manner
that benefits society at large and aligns with the interests of its stakeholders. In
accordance with section 135 and Schedule VII of the Companies Act, 2013, the Board of
Directors has constituted a CSR Committee.
The CSR Committee has developed a CSR Policy, which has been uploaded
to the company?s website at www.prevestdenpro.com.
The committee?s composition and the meetings held during the year
are as follows:
| Name of the Member |
Category |
Designation |
Meetings |
|
|
|
Held |
Attended |
| Mr. Atul Modi |
Managing Director |
Chairperson |
1 |
1 |
| Mrs. Namrata Modi |
Executive Director |
Member |
1 |
1 |
| Dr. Nikhil Shrikant Bobade |
Independent Director |
Member |
1 |
1 |
Subsequent to the close of the financial year ended 31 March 2026,
pursuant to the appointments and cessation of Directors on the Board, the Corporate Social
Responsibility Committee was reconstituted with effect from April 22, 2026 as under:
| Name of the Member |
Category |
Designation |
| Mrs. Atul Modi |
Managing Director |
Chairperson |
| Dr. Piyush Kiranprakeash Gupta |
Independent Director |
Member |
| Mrs. Namrata Modi |
Whole Time Director & CFO |
Member |
The reconstituted Corporate Social Responsibility Committee continues
to function in accordance with the applicable provisions of the Companies Act, 2013, and
its terms of reference. The disclosures as per Rule 9 of Companies (Corporate Social
Responsibility Policy) Rules, 2014 related to CSR activities is detailed in Annexure
D.
Annual Return
Pursuant to Section 92(3) of the Companies Act, 2013 read with Rule 12
of the Companies (Management and Administration) Rules, 2014, a copy of the Annual Return
of the Company for Financial Year 2025-26 prepared in accordance with Section 92(1) of the
Act has been placed on the website and is available at www.prevestdenpro.com/investors/annual-returns/.
Corporate Social Responsibility (csr) Committee
The Board of Directors of the Company has on the recommendation of the
Audit Committee, adopted a Related Party Transactions Policy for identifying, reviewing,
and approving transactions between the Company and the Related Parties, in compliance with
the applicable provisions of the Listing Regulations, the Act and the Rules thereunder
which is reviewed frequently by the Board, the policy is also available on the
Company?s website at www.prevestdenpro.com/investors/policies/.
The Company has a well-defined process of identification of related
parties and tracking transactions with related parties, its approval and review process.
All related party transactions entered into by the Company during the Financial Year
2025-26 were in the ordinary course of business and on an arm?s length basis. There
was no material related party transaction entered into by the Company with Promoters,
Directors, Key Managerial Personnel, or other related parties, which may have a potential
conflict with the interest of the Company at large.
The Audit Committee considered and granted Omnibus Approval for
entering into transactions with related parties for the Financial Year 2025-26, which are
repetitive in nature, at arm?s length and in ordinary course of business, which was
further approved by the Board. The transactions entered pursuant to the omnibus approval
so granted and a statement giving details of all transactions with related parties are
placed before the Audit Committee for quarterly review. The details of the related party
Transactions are set out in Notes to the Standalone Financial Statements forming part of
this Report.
Pursuant to the provisions of Section 188 of the Act read with rules
framed thereunder, the disclosure of particulars of contracts/arrangements with Related
Parties in Form AOC-2 is attached as Annexure E and forms part of this
Report.
Prevention Of Insider Trading:
The Company has adopted a Code of Conduct for Prevention of Insider
Trading, in accordance with the requirements of Securities and Exchange Board of India
(Prohibition of Insider Trading) Regulations, 2015 as amended from time to time. The
Company Secretary is the Compliance Officer for monitoring adherence to the said
Regulations. The Code is displayed on the Company?s website at www.prevestdenpro.com/investors/policies.
General Meetings
The Annual General Meeting of the Company was held at its registered
office through VC for the Financial Year 2025-26.
| Financial Year |
Nature of Meeting |
Time |
Date |
| 2025-26 |
AGM |
12.30PM |
10th September, 2025 |
Registrar And Share Transfer Agent Information
The Company has appointed Bigshare Services Private Limited as its
Registrar and Share Transfer Agent (RTA) to handle all investor-related services,
including share transfer, dematerialization, rematerialization, and other related
activities.
RTA Contact Details:
Big Share Service Private Limited
Office No: S6-2, 6th Floor, Pinnacle Business Park,
Next to Ahura Centre, Mahakali Caves Road,
Andheri (East) Mumbai - 400093 Tel :- +91 -22-262638200 Email:- aliya@bigshareonline.com
Disclosure Under The Sexual Harassment Of Women At Workplace Act And
Maternity Benefit Act
A.Sexual Harassment of Women at Workplace
In accordance with the provisions of the Sexual Harassment of Women at
Workplace (Prevention, Prohibition and Redressal) Act, 2013 and the Companies (Accounts)
Second Amendment Rules, 2025, the Company has implemented a comprehensive Prevention of
Sexual Harassment (POSH) Policy.
An Internal Complaints Committee (ICC) is duly constituted at the
corporate level to deal with complaints related to sexual harassment at the workplace. The
policy covers all categories of employees, including permanent, temporary, contractual,
interns, and trainees.
During the financial year ended March 31,2026, the following is
disclosed in accordance with the amended rules:
| Particular |
Number |
| Complaints received during the financial year |
0 |
| Complaints disposed of during the year |
0 |
| Complaints pending beyond 90 days |
0 |
| Total complaints pending as on March 31,2026 |
0 |
and training for employees and ICC members during the year. The ICC
functions independently and ensures a safe, respectful, and inclusive workplace
environment.
Number of Employees as on the closure of Financial year as under:
Male:119
Female:20
A.Compliance with the Maternity Benefit Act, 1961
In accordance with Rule 8A of the Companies
(Accounts) Rules, 2014 (inserted via the Companies (Accounts) Second
Amendment Rules, 2025), the Company hereby confirms that it has complied with the
provisions of the Maternity Benefit Act, 1961, including but not limited to:
Grant of paid maternity leave as per applicable law
Provision for nursing breaks
Non-discrimination in employment and benefits The Company
remains committed to providing a safe, equitable, and inclusive workplace for all its
employees.
Internal Financial Control And Their Adequacy
Your company has an effective internal control and risk- mitigation
system that is continuously assessed and strengthened through the implementation of new or
revised standard operating procedures. The internal control system of the company is
aligned with its size, scale, and complexity of operations.
The primary focus of the internal audit is to test and review controls,
assess risks, evaluate business processes, and compare controls with industry best
practices. The Audit Committee of the Board of Directors actively reviews the adequacy and
effectiveness of the internal control systems and provides recommendations for
improvements. The company utilizes a robust Management Information System, which is an
integral part of the control mechanism.
The Audit Committee, along with the Statutory Auditors and Business
Heads, is regularly briefed on the findings of the internal audit and the corrective
actions taken. The audit function plays a vital role in providing assurance to the Board
of Directors. Noteworthy audit observations and the corresponding corrective actions
implemented by the management are presented to the Audit Committee.
To maintain objectivity and independence, the Internal Audit function
reports to the Chairman of the Audit Committee.
Transfer Of Unclaimed Dividend And Equity Shares
To Investor Education And Protection Fund (IEPF)
Pursuant to Section 124 of the Act read with the Investor Education and
Protection Fund Authority (Accounting, Audit, Transfer and Refund Rules), 2016 ('the IEPF
Rules'), during the year under review, no amount of Unclaimed dividend and corresponding
equity shares were due to be transferred to IEPF account.
Environment And Safety
Your company is dedicated to ensuring a strong Safety, Health, and
Environmental (SHE) performance in relation to its activities, products, and services. It
takes consistent measures to develop safer process technologies and unit operations,
investing significantly in areas such as process automation to enhance safety and reduce
the potential for human error.
Additionally, the company emphasizes the importance of training in
process and behavior-based safety, as well as adopting production processes that are both
safe and environmentally friendly. The company maintains a continuous focus on improving
its management system to enhance safety and environmental practices.
Furthermore, your company is committed to continuously taking further
steps to provide a safe and healthy environment. This commitment reflects the ongoing
dedication to ensuring the well-being of employees, stakeholders, and the community at
large.
Significant And Material Orders Passed By The
Regulators Or Courts
There are no significant and material orders passed by the
Regulators/Courts that would impact the going concern status of the Company and its future
operations.
Non-Disqualification Of Directors
None of the Directors of the Company has been debarred or disqualified
from being appointed or continuing as director of Companies.
Secretarial Standards
The Company has complied with the applicable SS-1 (Secretarial Standard
on Meetings of the Board of Directors) and SS-2 (Secretarial Standard on General Meetings)
issued by the Institute of Company Secretaries of India.
Whistle Blower Policy/vigil Mechanism
The Company has Whistle Blower Policy/ Vigil Mechanism as required
under Companies Act. 2013 and as per Listing Obligations and Disclosures Requirements
Region Formulated by Securities and Exchange Board of India (SEBI) The Vigil (Whistle
Blower) mechanism provides a channel to the employees and Directors to report to the
management, concerns unethical behavior, actual or suspected fraud or violation of the
Code of Conduct or policy. The mechanism provides for adequate safeguards against
victimization of employees and Directors to avail the mechanism and also provide for
direct access to the Chairman of the Audit Committee in exceptional cases. The said policy
may be referred to at the Company's website at: www.prevestdenpro.com
Residual Disclosures
? During the year under review no application was made and no
proceedings were pending against the company under the Insolvency and Bankruptcy Code,
2016 (31 of 2016).
During the year under review there was no One Time settlement with any
bank or Financial Institution.
? The Company?s equity shares continue to remain listed on the
SME Platform of BSE Limited under Scrip Code 543363. The Company has duly paid the annual
listing fees for the financial year 2025-26.
Acknowledgment And Appreciation
Your Directors extend their heartfelt gratitude for the support and
cooperation received from Banks, Government Authorities, Shareholders, Suppliers, and
Customers. They also acknowledge and express their appreciation for the contributions made
by the employees at all levels, which have played a crucial role in achieving the
Company's goals.
Your Directors also highly value and appreciate the dedication and
commitment of every Member of the Prevest family.
| On behalf of the Board of Director |
|
Prevest Denpro Limited |
|
| Sd/- |
Sd/- |
| Atul Modi |
Namrata Modi |
| Managing Director |
Whole-time Director |
| DIN:00788272 |
D I N:00788266 |
| Date: 11/08/2026 |
|
| Place: Jammu |
|
|